Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1987-11-17
1989-04-11
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540560, 540568, C07D49512, C07D49504, A61K 3155
Patent
active
048207039
ABSTRACT:
A thienotriazolodiazepine compound of the formula: ##STR1## wherein A is alkylene or substituted alkylene and each other symbol is as defined in the specification and a pharmaceutically acceptable acid addition salt thereof, and pharmaceutical uses thereof.
Said compounds exhibit PAF-antagonistic activity and are useful for the prevention or treatment of various PAF-induced diseases.
REFERENCES:
patent: 3904641 (1975-09-01), Nakanishi
patent: 4155913 (1979-05-01), Hellerbach
patent: 4199588 (1980-04-01), Weber
patent: 4201712 (1980-05-01), Weber
Teresawa, Japanese Journal of Pharmacology, No. 4, vol. 44, pp. 381-391, Aug. 1987.
Yoshitomi Pharm. Co., Chemical Abstracts, vol. 94, p. 583, Abstract No. 47337w (1981).
Abe Masao
Moriwaki Minoru
Tahara Tetsuya
Yuasa Shuji
Berch Mark L.
Yoshitomi Pharmaceutical Industries Ltd.
LandOfFree
PAF-antagonistic thienotriazolodiazepine compounds and pharmaceu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PAF-antagonistic thienotriazolodiazepine compounds and pharmaceu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PAF-antagonistic thienotriazolodiazepine compounds and pharmaceu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-667394